IL6R inhibits viability and apoptosis of pancreatic beta-cells in type 2 diabetes mellitus via regulation by miR-22 of the JAK/STAT signaling pathway

References

• Organization WH. Global report on diabetes. Working Papers . 2016.
   Google Scholar
• Harris MI . Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med . 2002;346 (6):393-403.
   Web of Science ®Google Scholar
• Defronzo RA . Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med . 2000;133(1):73–74. doi:10.7326/0003-4819-133-1-200007040-00016 10877745
   PubMed Web of Science ®Google Scholar
• Roy T . Insulin resistance and type 2 diabetes. Diabetes . 2012;61(4):778–779. doi:10.2337/db12-0073 22442298
   PubMed Web of Science ®Google Scholar
• Heller RS . The comparative anatomy of Islets In: Islam MS , editor. Islets of Langerhans . 2 ed. Dordrecht: Springer Netherlands; 2013:1–16.
   Google Scholar
• Satin L , Butler P , Ha J , Sherman A . Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes. Mol Asp Med . 2015;42:62–67. doi:10.1016/j.mam.2015.01.003
   Web of Science ®Google Scholar
• Arcidiacono B , Iiritano S , Chiefari E , et al. Cooperation between HMGA1, PDX-1, and MafA is essential for glucose-induced insulin transcription in pancreatic beta cells. Front Endocrinol (Lausanne) . 2015;5:237. doi:10.3389/fendo.2014.00237 25628604
   PubMed Web of Science ®Google Scholar
• Cusi K . Lessons learned from studying families genetically predisposed to type 2 diabetes mellitus. Curr Diab Rep . 2009;9(3):200–207.19490821
   PubMed Web of Science ®Google Scholar
• Fried Dab Susank , Greenberg Andrews . Omental and subcutaneous adipose tissues of obese subjects release interleukin-6 depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab . 1999;83:847–850.
   Web of Science ®Google Scholar
• Mohamed-Ali V . JP, and SW Coppack. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord . 1998;22:1145–1158.9877249
   PubMed Web of Science ®Google Scholar
• Zhang SSL . Association of the D358A polymorphism of IL6R gene with type 2 diabetes in Hubei Han Chinese. Prog Mod Biomed . 2009;9(1):80–83.
   Google Scholar
• Pickup JC , Mattock MB , Chusney GD , Burt D . NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia . 1997;40(11):1286. doi:10.1007/s001250050836 9389420
   PubMed Web of Science ®Google Scholar
• Pickup JC , Crook MA . Is type II diabetes mellitus a disease of the innate immune system? Diabetologia . 1998;41(10):1241–1248. doi:10.1007/s001250051058 9794114
   PubMed Web of Science ®Google Scholar
• Nagata SKN . Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus. Acta Diabetol . 1999;36(1–2):67–72.10436255
   PubMed Web of Science ®Google Scholar
• Pedersen BK , Steensberg A , Schjerling P . Muscle-derived interleukin-6: possible biological effects. J Physiol . 2010;536(2):329–337. doi:10.1111/j.1469-7793.2001.0329c.xd
   Web of Science ®Google Scholar
• Sandler S , Bendtzen K , Eizirik DL , Welsh M . Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro. Endocrinology . 1990;126(2):1288–1294. doi:10.1210/endo-126-2-1288 2404746
   PubMed Web of Science ®Google Scholar
• Saad MF , Khan A , Sharma A , et al. Physiological insulinemia acutely modulates plasma leptin. Diabetes . 1998;47(4):544–549. doi:10.2337/diabetes.47.4.544 9568685
   PubMed Web of Science ®Google Scholar
• Vermes C , Jacobs JJ , Zhang J , Firneisz G , Roebuck KA , Glant TT . Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts. J Biol Chem . 2002;277(19):16879–16887. doi:10.1074/jbc.M200546200 11884403
   PubMed Web of Science ®Google Scholar
• Ambros V . The functions of animal microRNAs. Nature . 2004;431(7006):350–355. doi:10.1038/nature02871 15372042
   PubMed Web of Science ®Google Scholar
• Damavandi Z , Torkashvand S , Vasei M , Soltani BM , Tavallaei M , Mowla SJ . Aberrant expression of breast development-related MicroRNAs, miR-22, miR-132, and miR-212, in breast tumor tissues. J Breast Cancer . 2016;19(2):148–155. doi:10.4048/jbc.2016.19.2.148 27382390
   PubMed Web of Science ®Google Scholar
• Qiao DD , Yang J , Lei XF , et al. Expression of microRNA-122 and microRNA-22 in HBV-related liver cancer and the correlation with clinical features. Eur Rev Med Pharmacol Sci . 2017;21(4):742–747.28272709
   PubMed Web of Science ®Google Scholar
• Xia SS , Zhang GJ , Liu ZL , et al. MicroRNA-22 suppresses the growth, migration and invasion of colorectal cancer cells through a Sp1 negative feedback loop. Oncotarget . 2017;8(22):36266–36278. doi:10.18632/oncotarget.16742 28422727
   PubMedGoogle Scholar
• Qiu K , Huang Z , Huang Z , He Z , You S . miR-22 regulates cell invasion, migration and proliferation in vitro through inhibiting CD147 expression in tongue squamous cell carcinoma. Arch Oral Biol . 2016;66:92–97. doi:10.1016/j.archoralbio.2016.02.013 26943814
   PubMed Web of Science ®Google Scholar
• Fan W , Huang J , Xiao H , Liang Z . MicroRNA-22 is downregulated in clear cell renal cell carcinoma, and inhibits cell growth, migration and invasion by targeting PTEN. Mol Med Rep . 2016;13(6):4800–4806. doi:10.3892/mmr.2016.5101 27082730
   PubMed Web of Science ®Google Scholar
• Yuan Wang QW , Shi R . Meta analysis of association of ApoE gene polymorphisms with diabetic nephropathy. J Shanghai Jiaotong Univ . 2011;31(05):625–631.
   Google Scholar
• Liu X , Zhang A , Xiang J , Lv Y , Zhang X . miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway. Oncol Rep . 2016;36(3):1385–1392. doi:10.3892/or.2016.4971 27461244
   PubMed Web of Science ®Google Scholar
• Deng N , Li L , Gao J , et al. Hsa_circ_0009910 promotes carcinogenesis by promoting the expression of miR-449a target IL6R in osteosarcoma. Biochem Biophys Res Commun . 2018;495(1):189–196. doi:10.1016/j.bbrc.2017.11.028 29117539
   PubMed Web of Science ®Google Scholar
• Tüfekci KU , Meuwissen RLJ , Genç S . The Role of MicroRNAs in Biological Processes . Humana Press; 2014.
   Google Scholar
• Zhang XQ , Jing WL . Upregulation of miR-122 is associated with cardiomyocyte apoptosis in atrial fibrillation. Mol Med Rep . 2018;18(2):1745–1751. doi:10.3892/mmr.2018.9124 29901138
   PubMed Web of Science ®Google Scholar
• Xia HF , He TZ , Liu CM , et al. MiR-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf. Cel Physiol Biochem . 2009;23(4–6):347–358. doi:10.1159/000218181
   PubMedGoogle Scholar
• Long ZW , Wu JH , Cai H , Wang YN , Zhou Y . MiR-374b promotes proliferation and inhibits apoptosis of human GIST cells by inhibiting PTEN through activation of the PI3K/Akt pathway. Mol Cells . 2018;41(6):532–544. doi:10.14348/molcells.2018.2211 29902839
   PubMed Web of Science ®Google Scholar
• Estrella S , Garciadiaz DF , Codner E , Camachoguillén P , Pérezbravo F . Expression of miR-22 and miR-150 in type 1 diabetes mellitus: possible relationship with autoimmunity and clinical characteristics. Medicina Clínica . 2016;147:6. doi:10.1016/j.medcli.2016.05.016
   Web of Science ®Google Scholar
• Jovicic A , Zaldivar Jolissaint JF , Moser R , Silva Santos Mde F , Luthi-Carter R. MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington’s disease-related mechanisms. PLoS One . 2013;8(1):e54222. doi:10.1371/journal.pone.0054222 23349832
   PubMed Web of Science ®Google Scholar